Clínica Baviera, S.A. (BME:CBAV)

Clínica Baviera Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	296.76	265.72	227.07	198.45	173.25	122.63
Revenue Growth (YoY)	17.54%	17.02%	14.42%	14.55%	41.28%	-1.37%
Cost of Revenue	157.98	133.18	115.1	96.55	84.05	64.23
Gross Profit	138.78	132.54	111.97	101.9	89.2	58.4
Selling, General & Admin	13.93	13.93	12.09	11.69	9.87	7.82
Amortization of Goodwill & Intangibles	2.57	-	-	15	-	-
Other Operating Expenses	42.08	42.08	32.86	33.25	25.77	17.2
Operating Expenses	79.46	76.89	61.93	59.94	49.73	38.57
Operating Income	59.32	55.65	50.04	41.96	39.46	19.83
Interest Expense	-2.83	-1.22	-0.57	-0.42	-0.46	-0.54
Interest & Investment Income	-	0.3	0.15	0.07	0	0.01
Earnings From Equity Investments	-0.02	-0.02	-0.01	-0.06	-0.03	0.2
Currency Exchange Gain (Loss)	0.04	0.04	0.01	-0	-0	-
Other Non Operating Income (Expenses)	1.22	1.22	0.07	-0.4	-0.04	-0
EBT Excluding Unusual Items	57.73	55.96	49.68	41.15	38.93	19.51
Asset Writedown	0.03	0.03	-0.03	-0.47	-0.03	-
Other Unusual Items	-	-	-	-	-	0.68
Pretax Income	57.76	55.99	49.65	40.68	38.9	20.19
Income Tax Expense	16.35	14.86	12.92	10.53	10.97	6.05
Earnings From Continuing Operations	41.41	41.14	36.73	30.15	27.93	14.13
Minority Interest in Earnings	-0.93	-0.93	-0.76	-0.63	-0.54	-0.19
Net Income	40.48	40.21	35.97	29.52	27.39	13.94
Net Income to Common	40.48	40.21	35.97	29.52	27.39	13.94
Net Income Growth	9.19%	11.77%	21.86%	7.77%	96.46%	8.96%
Shares Outstanding (Basic)	16	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16	16
Shares Change (YoY)	0.16%	-1.85%	-	-	0.01%	-0.01%
EPS (Basic)	2.53	2.51	2.21	1.81	1.68	0.86
EPS (Diluted)	2.53	2.51	2.21	1.81	1.68	0.86
EPS Growth	9.01%	13.88%	21.86%	7.77%	96.43%	8.97%
Free Cash Flow	46.4	36	35.13	39.35	36.28	23.64
Free Cash Flow Per Share	2.90	2.25	2.15	2.41	2.23	1.45
Dividend Per Share	-	1.570	1.570	1.300	1.030	0.552
Dividend Growth	-	-	20.77%	26.21%	86.59%	-
Gross Margin	46.77%	49.88%	49.31%	51.35%	51.49%	47.62%
Operating Margin	19.99%	20.94%	22.04%	21.14%	22.78%	16.17%
Profit Margin	13.64%	15.13%	15.84%	14.88%	15.81%	11.37%
Free Cash Flow Margin	15.63%	13.55%	15.47%	19.83%	20.94%	19.28%
EBITDA	81.87	75.63	66.5	56.76	53.35	33.21
EBITDA Margin	27.59%	28.46%	29.29%	28.60%	30.80%	27.08%
D&A For EBITDA	22.55	19.98	16.46	14.8	13.89	13.38
EBIT	59.32	55.65	50.04	41.96	39.46	19.83
EBIT Margin	19.99%	20.94%	22.04%	21.14%	22.78%	16.17%
Effective Tax Rate	28.30%	26.53%	26.02%	25.89%	28.19%	29.99%
Advertising Expenses	-	12.14	10.31	9.86	8.42	5.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.